Search
Fennec Pharmaceuticals Inc
FENCAdd to Watchlist
10.700USD
+0.360+3.48%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
369.59MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Fennec Pharmaceuticals Inc is 8.57, ranking 26 out of 157 in the Pharmaceuticals industry. The average price target is 14.00, with a high of 17.00 and a low of 13.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
15.667
Target Price
+46.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Fennec Pharmaceuticals Inc
FENC
6
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
33
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Fennec Pharmaceuticals Inc's expected revenue for the next quarter?
Fennec Pharmaceuticals Inc's expected revenue is 16.12M.
What is Fennec Pharmaceuticals Inc's price target?
Analysts forecast that Fennec Pharmaceuticals Inc's price target is USD 14.00, with the highest forecast at USD 17.00 and the lowest forecast at USD 13.00.
How have Fennec Pharmaceuticals IncFENC's recent earnings per share performed?
The market expectation was USD 0.01, while Fennec Pharmaceuticals IncFENC's earnings per share (EPS) for the previous quarter was USD -0.15. EPS for the next quarter is expected at USD 0.01.
What is the analyst rating for Fennec Pharmaceuticals Inc?
Based on the ratings of Fennec Pharmaceuticals Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.